Literature DB >> 6149922

Magnesium, electrolyte transport and coronary vascular tone.

B M Altura, B T Altura.   

Abstract

Coronary heart diseases (CHD) have high indices of mortality and morbidity. A number of CHD and myocardial ischaemic syndromes such as unstable angina pectoris, sudden death ischaemic heart disease, acute myocardial infarction and ventricular arrhythmias have been associated with losses of myocardial magnesium and potassium. Mg++ ions are essential for regulation of Na+ and K+ transport across cell membranes, including those found in cardiac and vascular smooth muscle cells. Mg++ activates an Na+-K+-ATPase pump which in turn plays a major role in regulating Na+-K+ transport. Loss of cellular Mg++ results in loss of critically important phosphagens: MgATP and creatine phosphate. Thus, under conditions where cellular Mg++ is depleted (e.g. hypoxia, ischaemia, anoxia), the Na+-K+ pump and phosphagen stores will be compromised, leading to alterations in resting membrane potentials. Cellular Mg++ depletion has been found to result in concomitant depletion of K+ in a number of cells, including cardiac and vascular muscles. The consequences of these events are often production of cardiac arrhythmias. Myocardial and vascular injury lead to disturbances in electrolyte transport across cell membranes, whereby Na+ and Ca++ uptakes are enhanced and, just prior or concomitantly, Mg++ and K+ are lost. Such electrolyte disturbances often lead to necrotic foci. Considerable evidence has accumulated to indicate that the extracellular concentration of Mg++ is important in control of arterial tone and blood pressure via pressure via regulation of vascular membrane Mg++-Ca++ exchange sites. A reduction in the extracellular Mg++ concentration can produce hypertension, coronary vasospasm and potentiation of vasoconstrictor agents by allowing excess entry of Ca++; concomitantly, the potency of vasodilator agents is reduced. Alterations in vascular membrane Mg++ results in arterial and arteriolar membranes which are 'leaky', thus contributing to the cellular reduction in K+ and gain of Na+ and Ca+. Alterations in extracellular K+ or Na+ concentrations over physiological ranges, in the face of a Mg++ deficit, can exacerbate the coronary vasospasm noted with reduction in only extracellular Mg++. Since free Mg++ ions are necessary for maintaining Ca+ ions (both plasma membrane-bound and sarcoplasmic reticulum membrane-bound via Ca++ ATPases), intracellular free Mg++ would rise in conditions which result in cellular loss of Mg++, thereby exacerbating and contributing to elevation of blood pressure and coronary vasospasm.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149922     DOI: 10.2165/00003495-198400281-00013

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  124 in total

1.  Mg2+ and the permeability of heart mitochondria to monovalent cations.

Authors:  J P Wehrle; M Jurkowitz; K M Scott; G P Brierley
Journal:  Arch Biochem Biophys       Date:  1976-05       Impact factor: 4.013

2.  Effects of magnesium on contractile responses induced by electrical transmural stimulation and noradrenaline in rabbit thoracic aorta.

Authors:  M Fujiwara; H Kitagawa; K Kurahashi
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

Review 3.  Magnesium and its significance in cardiovascular and gastro-intestinal disorders.

Authors:  I Szelényi
Journal:  World Rev Nutr Diet       Date:  1973       Impact factor: 0.575

4.  Magnesium deficiency. Role in arrhythmias complicating acute myocardial infarction?

Authors:  R P Bigg; R Chia
Journal:  Med J Aust       Date:  1981-04-04       Impact factor: 7.738

5.  Studies on digitalis. XIV. Is there any correlation between hypomagnesemia and digitalis intoxication?

Authors:  O Storstein; V Hansteen; L Hatle; L Hillestad; L Storstein
Journal:  Acta Med Scand       Date:  1977

6.  Magnesium and deaths ascribed to ischaemic heart disease in South Africa. A preliminary report.

Authors:  W P Leary; A J Reyes; C J Lockett; D D Arbuckle; K van der Byl
Journal:  S Afr Med J       Date:  1983-11-05

7.  Pharmacologic inhibition of cerebral vasospasm in ischemia, hallucinogen ingestion, and hypomagnesemia: barbiturates, calcium antagonists, and magnesium.

Authors:  B M Altura; B T Altura
Journal:  Am J Emerg Med       Date:  1983-09       Impact factor: 2.469

8.  The effect of magnesium on the response of smooth muscle to 5-hydroxytryptamine.

Authors:  S Goldstein; T T Zsotér
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

9.  Studies on magnesium's mechanism of action in digitalis-induced arrhythmias.

Authors:  M J Specter; E Schweizer; R H Goldman
Journal:  Circulation       Date:  1975-12       Impact factor: 29.690

10.  Myocardial infarction and water hardness in European towns.

Authors:  R Masironi; Z Pisa; D Clayton
Journal:  J Environ Pathol Toxicol       Date:  1980-09
View more
  14 in total

1.  Does dietary magnesium modulate blood lipids?

Authors:  R B Singh; S S Rastogi; U V Mani; J Seth; L Devi
Journal:  Biol Trace Elem Res       Date:  1991-07       Impact factor: 3.738

2.  Longitudinal Assessment of Calcium and Magnesium Levels in Women with Preeclampsia.

Authors:  Nisha Wadhwani; Kamini Dangat; Karuna Randhir; Anupam Poddar; Prachi Joshi; Hemlata Pisal; Vrushali Kadam; Ravleen Bakshi; Nomita Chandhiok; Sanjay Lalwani; Savita Mehendale; Girija Wagh; Sanjay Gupte; Harshpal Singh Sachdev; Caroline Fall; Sadhana Joshi
Journal:  Biol Trace Elem Res       Date:  2022-10-10       Impact factor: 4.081

3.  Magnesium content of erythrocytes in patients with vasospastic angina.

Authors:  K Tanabe; K Noda; T Mikawa; M Murayama; J Sugai
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

4.  Magnesium and potassium. Inter-relationships in cardiac disorders.

Authors:  M R Wills
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Magnesium depletion in patients on long-term chlorthalidone therapy for essential hypertension.

Authors:  G Cocco; H U Iselin; C Strozzi; B Cesana; H R Baumeler
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Magnesium dietary intake modulates blood lipid levels and atherogenesis.

Authors:  B T Altura; M Brust; S Bloom; R L Barbour; J G Stempak; B M Altura
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  Importance of magnesium and potassium concentration on basal tone and 5-HT-induced contractions in canine isolated coronary artery.

Authors:  T Murakawa; B T Altura; A Carella; B M Altura
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

Review 8.  Magnesium, myocardial ischaemia and arrhythmias. The role of magnesium in myocardial infarction.

Authors:  A Dubey; R Solomon
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

Review 9.  Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.

Authors:  A W Hoes; D E Grobbee; T M Peet; J Lubsen
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

10.  Intracellular magnesium concentrations and acute anthracycline-induced cardiotoxicity.

Authors:  S Sartori; I Nielsen; D Tassinari; A Maestri; V Abbasciano
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.